We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
62 hedge funds and large institutions have $141M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 12 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
480% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 5
284% more call options, than puts
Call options by funds: $748K | Put options by funds: $195K
65% more capital invested
Capital invested by funds: $85.1M → $141M (+$55.6M)
63% more funds holding
Funds holding: 38 → 62 (+24)
33% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 9
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
62
Holders Change
+24
Holders Change %
+63.16%
% of All Funds
1.1%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
29
Increased
12
Reduced
9
Closed
5
Calls
$748K
Puts
$195K
Net Calls
+$553K
Net Calls Change
+$134K
Top Buyers
| 1 |
CCM
Consonance Capital Management
New York
|
+$8.36M |
| 2 |
GTC
Ghost Tree Capital
New York
|
+$2.49M |
| 3 |
Millennium Management
New York
|
+$1.27M |
| 4 |
Morgan Stanley
New York
|
+$1.25M |
| 5 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$998K |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$5.7M |
| 2 |
CC
Caxton Corporation
Princeton,
New Jersey
|
-$1.88M |
| 3 |
Renaissance Technologies
New York
|
-$1.32M |
| 4 |
Two Sigma Advisers
New York
|
-$367K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$109K |
